ABOUT EGC
Company profile
About us
EGC Therpauetics
Creates novel biomaterial technologies for tissue engineering and regenerative medicine using Enzymes, Genomics, and Cells
Technology
Enzyme-based approach to develop biomedical device and pharma/cosmetics
Enzyme technology
Immuno-isolation
- Encapsulation technology
- Beta cell coating for Type I diabetes
- Organoids
Biomedical devices
- Synthetic bone substitute
- Alveolar bone, avascular bone necrosis
- Hydrogel medical device
Additional applications
- Melanin hair dyeing
- Protein modification
- Cosmetic ingredients
- Ab-based diagnosis
- Scaffold for alternative meat
Company History
2024
- 06Extension of R&D facility
- 01Approval of ISO 13485: 2016
GMP facility Establishment
2023
- 03Securement of seed funding
- 01R&D Grant (MOTIE)
Head office relocation (SNU → Nakseongdae R&D center)
Securement of angel investment
2022
- 05Startup Package Grant (KISED)
- 04Invitation of advisory board
- 01R&D Grant (National Research Foundation of Korea)
2021
- 12Accreditation of an Affiliated research institute
- 07Company establishment